Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
678 studies found for:    Open Studies | "Pancreatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
22 Not yet recruiting Follow-up Study of Complications of Acute Pancreatitis
Conditions: Pancreatitis;   Pancreatic Neoplasms;   Metabolic Diseases;   Hypertension, Portal;   Respiratory Failure;   Quality of Life
23 Recruiting BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
Conditions: Advanced Solid Tumors;   Metastatic Colorectal Cancer;   Metastatic Pancreatic Cancer
Interventions: Drug: BKM120;   Drug: mFOLFOX6
24 Recruiting Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy
Condition: Disease of Pancreatic Head or Periampullary Lesions to Require Pancreaticoduodenectomy
Intervention: Procedure: pancreaticoduodenectomy
25 Recruiting Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
Conditions: Critical Illness;   Sepsis;   Diabetes;   Cardiac Arrest;   Acute Renal Failure;   Shock
Intervention: Dietary Supplement: Enteral nutrition (EN)
26 Recruiting Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
Condition: Resectable Pancreatic Carcinoma
Interventions: Radiation: chemoradiotherapy with Gemcitabine;   Radiation: Radiation: chemoradiotherapy with Gemcitabine
27 Recruiting Effect of Early Mechanical Ventilation to Severe Acute Pancreatitis
Conditions: Acute Pancreatitis;   Complication of Ventilation Therapy
Interventions: Other: early mechanical Ventilation;   Other: Conventional Mechanical Ventilation
28 Recruiting Whipple Procedure: Standard of Care vs. Thunderbeat
Conditions: Pancreatic Neoplasms;   Bile Duct Carcinoma
Interventions: Device: Thunderbeat;   Device: EnSeal
29 Recruiting Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Sitagliptin
30 Unknown  Stereotactic Body Radiation Therapy With or Without Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Radiation: stereotactic body radiation therapy
31 Recruiting Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Conditions: Gastrinoma;   Glucagonoma;   Insulinoma;   Pancreatic Polypeptide Tumor;   Recurrent Islet Cell Carcinoma;   Somatostatinoma
Interventions: Drug: dovitinib lactate;   Other: pharmacological study;   Other: laboratory biomarker analysis
32 Recruiting Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Conditions: Gastrinoma;   Glucagonoma;   Insulinoma;   Pancreatic Polypeptide Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Pancreatic Cancer;   Somatostatinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: capecitabine;   Drug: temozolomide;   Biological: bevacizumab
33 Recruiting Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
Conditions: Pancreatic Cancer;   Periampullary Tumor
Interventions: Procedure: Hepaticojejunostomy and gastroenterostomy;   Procedure: Stent strategy
34 Recruiting Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)
Conditions: Pancreatic Cancer Stage II;   Pancreatic Cancer Stage III
Interventions: Drug: Neoadjuvant gemcitabine, capecitabine, and docetaxel;   Drug: Gemcitabine, capecitabine, docetaxel followed by radiotherapy
35 Recruiting An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine
Condition: Pancreatic Cancer
Intervention: Procedure: Positron-Emission Tomography (PET) 18F-FLT
36 Unknown  Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®
Condition: Cystic Fibrosis
Interventions: Drug: Nebcinal Tobi;   Drug: Tobi Nebcinal
37 Recruiting Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.
Condition: Cystic Fibrosis
38 Recruiting Impact of Immunonutrition on the Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis;   Malnutrition;   Oxidative Stress
Interventions: Dietary Supplement: Impact-Nutridrink;   Dietary Supplement: Nutridrink-Impact
39 Unknown  Cystic Fibrosis - Insulin Deficiency, Early Action
Conditions: Cystic Fibrosis;   Diabetes
Intervention: Drug: Once-daily insulin detemir
40 Recruiting Quality of Life After Surgery for Pancreatic Carcinoma
Condition: Patients Suspected for a Pancreatic (Pre-)Malignancy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years